This article was originally published in The Gray Sheet
German Armed Forces purchases bench-top PSQ 96 system for typing and validation of bacteria and viruses used to produce biological weapons, such as anthrax and smallpox. Additional European defense organizations have expressed interest in the system, the Swedish firm announced Nov. 29. The single nucleotide polymorphism technology for identification and quantification of short DNA sequences, which offers results in as little as 10 minutes and costs about $90,000, is currently being used for research purposes and environmental testing. In the future, Pyrosequencing expects to partner with labs to develop clinical assays for a wide range of indications...
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.